flufenamic acid has been researched along with Triple Negative Breast Neoplasms in 1 studies
Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Z | 2 |
| Yang, C | 1 |
| Zhang, H | 1 |
| Gao, Y | 1 |
| Xiao, M | 1 |
| Yang, L | 1 |
| Zhang, J | 1 |
| Ren, C | 1 |
| Liu, J | 1 |
1 other study available for flufenamic acid and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Topics: Cell Line, Tumor; Esterases; Flufenamic Acid; Glutathione; Hippo Signaling Pathway; Humans; Nanomedi | 2022 |